{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Pathologies&page=7", "query": { "condition": "Multiple Pathologies", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 3386, "total_pages": 339, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Pathologies&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Pathologies&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T21:39:53.999Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05859074", "title": "A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cutaneous Squamous Cell Carcinoma", "SCC - Squamous Cell Carcinoma", "Basal Cell Carcinoma", "BCC", "BCC - Basal Cell Carcinoma", "Melanoma", "Merkel Cell Carcinoma", "Sebaceous Carcinoma", "Extramammary Paget Disease", "Kaposi Sarcoma", "Head and Neck Squamous Cell Carcinoma", "HNSCC", "Adnexal Carcinoma", "Angiosarcoma", "Cutaneous Neoplasm", "Advanced Cancer", "Metastatic Cancer", "Refractory Cancer", "Solid Tumor" ], "interventions": [ { "name": "MQ719", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2023-05-04", "completion_date": "2028-05-04", "has_results": false, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05859074" }, { "nct_id": "NCT00597818", "title": "Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NSAID-induced Gastroduodenal Injury", "Ulcers", "Rheumatoid Arthritis", "Osteoarthritis" ], "interventions": [ { "name": "Cobiprostone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Non-steroidal anti-inflammatory drug", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sucampo Pharma Americas, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 121, "start_date": "2007-08", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2019-12-26", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Chula Vista, California • Loma Linda, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00597818" }, { "nct_id": "NCT00041925", "title": "Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Peripheral Vascular Diseases", "Arterial Occlusive Diseases", "Ischemia", "Graft Occlusion, Vascular", "Hyperplasia" ], "interventions": [ { "name": "CGT003 (E2F Duplex Decoy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anesiva, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1400, "start_date": "2001-11", "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2005-07-15", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 116, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041925" }, { "nct_id": "NCT00102518", "title": "Aripiprazole Open-Label, Safety and Tolerability Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia", "Bipolar Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 325, "start_date": "2004-09", "completion_date": "2007-02", "has_results": true, "last_update_posted_date": "2012-08-31", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Costa Mesa, California + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00102518" }, { "nct_id": "NCT06042413", "title": "Prediction and Prevention of Postoperative Mortality and Morbidity", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Postoperative Delirium (POD)", "Postoperative Neurocognitive Disorder", "Major Adverse Cardiac and Cerebrovascular Events", "Perioperative Complications", "Postoperative Cognitive Decline" ], "interventions": [ { "name": "Personalized CPC Prehabilitation", "type": "OTHER" }, { "name": "Cognitive Training", "type": "BEHAVIORAL" }, { "name": "Meditation", "type": "BEHAVIORAL" }, { "name": "Daily Exercise", "type": "BEHAVIORAL" }, { "name": "Enhanced Social Support", "type": "BEHAVIORAL" }, { "name": "Proactive Bundle Interventions", "type": "OTHER" }, { "name": "Pre-operative Standard of Care", "type": "PROCEDURE" }, { "name": "Intra-operative Standard of Care", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1200, "start_date": "2026-11", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 5, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06042413" }, { "nct_id": "NCT03913689", "title": "StimRouter Registry Clinical Protocol", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pain", "Peripheral Neuropathy", "Nervous System Diseases", "Peripheral Nervous System Diseases", "Peripheral Nervous System Problem", "Peripheral Nerve Injuries", "Peripheral Nervous" ], "interventions": [ { "name": "StimRouter Neuromodulation System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Bioness Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2019-06-26", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2025-05-20", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 9, "location_summary": "La Jolla, California • Larkspur, California • Redwood City, California + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Larkspur", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03913689" }, { "nct_id": "NCT06451159", "title": "A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Progressive Multiple Sclerosis" ], "interventions": [ { "name": "KYV-101 (Biological) - 0.33 ×10^8 cells", "type": "BIOLOGICAL" }, { "name": "KYV-101 (Biological) - 1 ×10^8 cells", "type": "BIOLOGICAL" }, { "name": "Chemotherapy: cyclophosphamide (CYC)", "type": "DRUG" }, { "name": "Chemotherapy: fludarabine (FLU)", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Bruce Cree", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "25 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2024-06-20", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06451159" }, { "nct_id": "NCT02532725", "title": "Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity", "Gender", "Problem of Aging" ], "interventions": [ { "name": "Cardiopulmonary Exercise Stress Test", "type": "PROCEDURE" }, { "name": "Climatic-Controlled Cardiopulmonary Exercise Stress Test", "type": "PROCEDURE" }, { "name": "Body Composition Evaluation", "type": "PROCEDURE" }, { "name": "Pre-Exercise Risk Assessment", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Freeman-Sheldon Research Group, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "35 Years to 55 Years · Male only" }, "enrollment_count": 12, "start_date": "1972-06", "completion_date": "1972-12", "has_results": false, "last_update_posted_date": "2015-08-26", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 1, "location_summary": "Buckhannon, West Virginia", "locations": [ { "city": "Buckhannon", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02532725" }, { "nct_id": "NCT00562224", "title": "Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms by Site", "Lymphoma, Non-hodgkin", "Hodgkin Disease", "Multiple Myeloma", "Leukemia, Lymphocytic, Chronic" ], "interventions": [ { "name": "PCI-24781", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pharmacyclics LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2007-11", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2011-09-28", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 4, "location_summary": "Greenbrae, California • Chicago, Illinois • Nashville, Tennessee + 1 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00562224" }, { "nct_id": "NCT04001088", "title": "The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Menopause" ], "interventions": [ { "name": "Probiotic", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Lallemand Health Solutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "59 Years", "sex": "FEMALE", "summary": "40 Years to 59 Years · Female only" }, "enrollment_count": 144, "start_date": "2019-07-29", "completion_date": "2021-04-23", "has_results": false, "last_update_posted_date": "2023-02-02", "last_synced_at": "2026-11-06T21:39:53.999Z", "location_count": 5, "location_summary": "Lake Worth, Florida • Port Saint Lucie, Florida • Atlanta, Georgia + 2 more", "locations": [ { "city": "Lake Worth", "state": "Florida" }, { "city": "Port Saint Lucie", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Henderson", "state": "Nevada" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT04001088" } ] }